Update

Immediate Release: February 6, 2003 SOPHEON PLC ('Sopheon') UPDATE Sopheon plc advises the market that is not aware of any corporate actions which could be the cause of the recent movement in its share price. While very encouraged by the rise, Sopheon emphasises that it has limited recent corporate activities to matters outstanding from 2003 divestments, and to supporting its balance sheet position. Key examples are ongoing negotiations over earnouts and asset transfer values with the purchaser of the group's Information Management business, negotiation and conclusion of a €10m equity line facility with GEM Global Yield Fund Limited, and the recent placing of 3,600,000 shares for gross proceeds of £828,000. The board remains committed to delivering Sopheon's long-term business objectives and is encouraged by the positive effect on the business of the significant corporate activity undertaken over the last 12 months. Management is focused on building on the positive developments of the final quarter of 2003, in a market in which the investment climate and the quality of sales pipeline activity continue to show real signs of improvement over previous periods. The company intends to release its 2003 preliminary results around the end of March, and will make further announcements when a date is confirmed. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Barbara Jansen Citigate First Financial Tel : + 31 (0) 205 754 010 About Sopheon Sopheon (LSE: SPE) is an international provider of software and services that help organizations improve the business impact of product development. The Sopheon Accolade® product development system automates gate- or phase-based product development processes and provides strategic decision support that allows companies to improve innovation, cut product development spending waste and shorten time to market. Sopheon's Monitor software operates as a 'reading robot' that automatically reviews, filters, analyzes and pushes relevant content to healthcare and engineering professionals to enable effective compliance with protocols, standards and regulations. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

Companies

Sopheon (SPE)
UK 100

Latest directors dealings